Access Statistics for Matthew J. Higgins

Author contact details at EconPapers.

Working Paper File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
Accounting for Price Endogeneity in Airline Itinerary Choice Models: An Application to Continental U.S. Markets 0 1 2 40 2 4 7 24
Assets with "Warts": How Reliable is the Market for Technology? 0 0 0 7 0 0 1 28
Behind the Scenes: Sources of Complementarity in R&D 0 0 0 16 0 1 5 59
Black Populations and Economic Growth: An Extreme Bounds Analysis of Mississippi County-Level Data 0 0 1 34 0 1 4 238
Black Populations and Economic Growth: An Extreme Bounds Analysis of Mississippi County-level Data 0 0 1 17 0 2 5 104
Conveying Quality and Value in Emerging Industries: Star Scientists and the Role of Learning in Biotechnology 0 1 1 34 0 1 5 195
Corporate Venture Capital as a Real Option in the Markets for Technology 0 1 9 64 0 1 13 69
Explaining Preferences for Control Rights in Strategic Alliances: A Property Rights and Capabilities Perspective Approach 0 0 0 26 0 1 3 60
Federal, State, and Local Governments: Evaluating Their Separate Roles in U.S. Growth 0 0 0 27 0 0 4 111
Federal, State, and Local Governments: Evaluating Their Separate Roles in U.S. Growth 0 0 1 25 0 0 3 89
Federal, State, and Local Governments: Evaluating their Separate Roles in US Growth 0 0 0 60 0 2 5 339
Federal, State, and Local Governments: Evaluating their Separate Roles in US Growth 0 0 1 46 0 2 5 336
Federal, State, and Local Governments:Evaluating their Separate Roles in US Growth 0 0 0 10 1 2 5 122
Growth and Convergence across the U.S.: Evidence from County-level Data 0 0 0 255 0 1 7 686
Growth and Convergence across the U.S.: Evidence from County-level Data 0 0 0 72 0 3 3 252
Growth and Convergence across the U.S: Evidence from County-Level Data 0 0 0 253 0 3 4 692
Growth and Convergence across the US: Evidence from County-Level Data 0 0 0 200 0 2 3 555
Growth and Convergence across the US: Evidence from County-Level Data 0 0 1 6 0 2 6 72
Growth and Convergence across the US: Evidence from County-Level Data 0 0 0 8 0 4 7 81
Heterogeneity in Convergence Rates and Income Determination across U.S. States: Evidence from County-Level Data 0 0 0 209 0 2 5 1,090
Heterogeneity in Convergence Rates and Income Determination across U.S. States: Evidence from County-Level Data 0 0 0 2 0 0 3 47
Heterogeneity in Convergence Rates and Income Determination across U.S. States: Evidence from County-level Data 0 0 0 65 0 0 3 292
Heterogeneous Convergence 0 0 0 35 1 9 75 243
Heterogeneous Convergence 0 0 0 13 0 0 0 66
Heterogeneous Convergence 0 0 2 54 0 1 7 157
Heterogeneous Convergence 0 0 0 36 0 0 1 122
Heterogeneous Convergence 0 0 0 48 0 0 4 55
Heterogeneous Convergence 0 0 0 14 0 0 4 57
Heterogeneous Convergence 0 0 0 5 0 1 5 32
Intra-alliance performance, control rights, and today's split of tomorrow's value 0 0 0 84 0 1 3 205
Many Types of Human Capital and Many Roles in U.S. Growth: Evidence from County-Level Educational Attainment Data 0 0 0 8 0 1 1 71
Many Types of Human Capital and Many Roles in U.S. Growth: Evidence from County-Level Educational Attainment Data 0 1 2 412 19 52 250 3,273
Many Types of Human Capital and Many Roles in U.S. Growth: Evidence from County-level Educational Attainment Data 1 1 1 67 1 2 3 325
Market Effects of Adverse Regulatory Events: Evidence from Drug Relabeling 0 1 6 6 1 4 14 14
Moving Beyond the Valley of Death: Regulation and Venture Capital Investments in Early-Stage Biopharmaceutical Firms 0 1 38 38 0 3 30 30
Regulation and Welfare: Evidence from Paragraph IV Generic Entry in the Pharmaceutical Industry 0 0 0 48 0 1 12 201
Robust Correlates of County-Level Growth in the U.S 0 0 0 36 0 1 3 157
Robust Correlates of County-level Growth in the U.S 0 0 0 18 0 1 2 80
Sigma Convergence Versus Beta Convergence: Evidence from County-level Data 0 0 0 1,790 0 1 4 4,435
Sigma Convergence Versus Beta Convergence: Evidence from U.S. County-Level Data 1 1 2 26 2 2 9 99
Sigma Convergence Versus Beta Convergence: Evidence from U.S. County-Level Data (revised version) 1 1 1 27 1 1 4 83
Sigma Convergence versus Beta Convergence: Evidence from U.S. County-Level Data 0 0 2 142 0 2 9 492
Sigma-Convergence Versus Beta-Convergence: Evidence from U.S. County-Level Data 0 0 1 514 0 3 10 1,608
Starving (or Fattening) the Golden Goose?: Generic Entry and the Incentives for Early-Stage Pharmaceutical Innovation 0 0 0 36 1 3 5 42
The Direct and Indirect Effects of Small Business Administration Lending on Growth: Evidence from U.S. County-Level Data 0 0 0 53 0 5 10 82
The Direct and Indirect Effects of Small Business Administration Lending on Growth: Evidence from U.S. County-Level Data 0 0 0 45 0 0 4 74
The Effect of Contractual Complexity on Technology Sourcing Agreements 0 2 2 40 2 5 9 231
The Impact of Patenting on New Product Introductions in the Pharmaceutical Industry 0 0 0 116 0 1 3 368
The Outsourcing of R&D through Acquisitions in the Pharmaceutical Industry 2 3 5 364 2 4 13 946
Total Working Papers 5 14 79 5,551 33 138 600 19,089


Journal Article File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
Behind the Scenes: Sources of Complementarity in R&D 0 0 1 2 0 1 9 27
Conveying quality and value in emerging industries: Star scientists and the role of signals in biotechnology 0 0 0 11 0 0 6 100
Federal, state, and local governments: evaluating their separate roles in US growth 0 0 0 30 0 1 2 158
Growth and Convergence across the United States: Evidence from County-Level Data 1 1 5 128 2 2 12 318
Heterogeneous convergence 0 0 0 33 0 1 5 96
Productivity and the role of complementary assets in firms' demand for technology innovations 0 0 0 16 0 0 2 83
Robust correlates of county-level growth in the United States 0 0 0 10 0 0 1 40
Sigma Convergence versus Beta Convergence: Evidence from U.S. County-Level Data 0 2 10 293 1 6 24 1,109
Strategic Alliances: Trading Ownership for Capabilities 0 0 0 8 0 0 1 32
The allocation of control rights in pharmaceutical alliances 0 0 2 54 0 0 5 138
The balance of payments crisis in the euro area periphery 2 7 22 120 4 23 82 458
The outsourcing of R&D through acquisitions in the pharmaceutical industry 0 0 7 238 0 3 26 715
Total Journal Articles 3 10 47 943 7 37 175 3,274


Statistics updated 2019-07-03